Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000596129 | SCV000701663 | uncertain significance | not provided | 2018-02-03 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000765252 | SCV000896500 | uncertain significance | Nephronophthisis 4; Senior-Loken syndrome 4 | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001046237 | SCV001210131 | uncertain significance | Nephronophthisis | 2024-10-26 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 769 of the NPHP4 protein (p.His769Leu). This variant is present in population databases (rs200821373, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of NPHP4-related conditions (PMID: 36474027). ClinVar contains an entry for this variant (Variation ID: 497253). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Daryl Scott Lab, |
RCV002245030 | SCV002515361 | uncertain significance | Senior-Loken syndrome 4 | 2022-02-01 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000596129 | SCV005186969 | uncertain significance | not provided | criteria provided, single submitter | not provided |